A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology

NCT01886820 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia
Alzheimer's Disease

Interventions

DRUG: [18F]NAV4694

Sponsor

Navidea Biopharmaceuticals